Smith Jason Drew — SEC Form 4 filings
SEC reporting owner CIK 1821479. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-02 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 8 filings — 36,926 shares, $644,374 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 7,522 shares @ $19.14 ($143,971) in UroGen Pharma Ltd., filed 2025-07-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | General Counsel | 8 | — | 16 legs · 36,926 sh · $644,374 | 28 |
Form 4 filings — Smith Jason Drew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 3,334 · Sale (S): 1,519 @ $42.54 · Option exercise (M): 3,334 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 5,500 · Sale (S): 2,654 @ $19.69 · Option exercise (M): 3,333 · Sale (S): 1,608 @ $19.69 · Option exercise (M): 6,667 · Sale (S): 3,217 @ $19.69 · +4 more | EDGAR |
| 2025-09-09 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 3,333 · Sale (S): 1,520 @ $19.11 · Option exercise (M): 3,333 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 16,500 · Sale (S): 7,522 @ $19.14 | EDGAR |
| 2025-02-04 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 2,500 · Sale (S): 1,258 @ $11.14 · Option exercise (M): 6,667 · Sale (S): 3,354 @ $11.14 · Option exercise (M): 5,500 · Sale (S): 2,767 @ $11.14 · +4 more | EDGAR |
| 2024-09-12 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 3,333 · Sale (S): 1,521 @ $13.08 · Option exercise (M): 3,333 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4/A | UroGen Pharma Ltd. (URGN) | Sale (S): 417 @ $15.78 · Sale (S): 1,248 @ $15.78 · Sale (S): 3,328 @ $15.78 | EDGAR |
| 2024-02-02 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 834 · Sale (S): 417 @ $15.74 · Option exercise (M): 2,500 · Sale (S): 1,248 @ $15.74 · Option exercise (M): 6,666 · Sale (S): 3,328 @ $15.74 · +4 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821479 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →